ArticleJournal of medical case reports2025
Conjunctival malignant melanoma in a young immunocompetent male patient: clinical presentation and management-a case report.
Article in Journal of medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundConjunctival melanoma is a rare yet aggressive ocular surface malignancy, with an incidence of approximately 0.2-0.8 cases per million individuals annually. It predominantly affects older adults, making its occurrence in younger individuals exceedingly rare and diagnostically challenging. CASE PRESENTATION: We report a 30-year-old Syrian male presenting with a progressively enlarging pigmented lesion on the temporal-inferior conjunctiva of the right eye. The lesion, noted since adolescence, demonstrated significant growth over the past 3 years. Comprehensive clinical assessment and imaging studies confirmed the presence of a well-vascularized, mobile conjunctival lesion, with no evidence of intraocular extension. Surgical excision with 1 mm safety margins was performed, followed by ocular surface reconstruction using a cryopreserved amniotic membrane graft. Histopathological analysis revealed a malignant melanoma with epithelioid and spindle cell morphology and tumor-free margins. Postoperative recovery was uneventful, with full epithelialization by 1 week and no evidence of recurrence at the 1-year follow-up.
conclusionTimely diagnosis and a multidisciplinary surgical approach are essential for achieving optimal outcomes in conjunctival melanoma, particularly in young patients. Complete excision with negative margins combined with amniotic membrane grafting ensures effective oncologic control and functional ocular surface restoration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.